Skip to main content
Caplight Logo









VisionHealth

VisionHealth

Private
MunichHealthcare & Life Scienceshttps://visionhealth.gmbh/

Last Round

Seed

Feb 27, 2023

Total Funding Raised

$4.27M

Company Overview

VisionHealth is a digital health company that develops a digital therapeutics application designed to improve the delivery of inhaled drug treatments for chronic lung diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

digital therapeuticsDTxmedical deviceinhalation therapytherapy adherencemedication adherencerespiratory diseasecomputer visionAI health apppatient engagementhealthcare analyticsremote patient monitoringRPMclinical trial supportmHealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VisionHealth Comparables

Compare VisionHealth with similar companies based on industry and business-model similarity.

VisionHealth comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Amiko Digital Health
79%
AptarGroup
74%
Adherium Limited
69%

VisionHealth Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 27, 2023
VC RoundFeb 26, 2021
SeedApr 28, 2020
VC RoundJul 16, 2019

Key People

Founding team and executive leadership

Sabine Häussermann

Chief Scientific Officer, Founder

Founding Team

Peter Shadday

CEO, VisionHealth, President, VisionHealth Inc., Chief Business Officer

Executive Team

VisionHealth Investors

Notable investors and investment history

VisionHealth investors
InvestorRounds
Sanner VenturesSeed, VC Round
Vantage ValueVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors grew 134% MoM, reaching 2K.

  • Feb 18, 2025

    Leadership change announced ahead of Kata app U.S. launch.

VisionHealth Filings

Explore SEC and related filing metadata, where available.

VisionHealth filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about VisionHealth's valuation, stock price, and market status.

Is VisionHealth a public or private company?

VisionHealth is a private company.

What is the current stock price of VisionHealth?

VisionHealth is a private company with no public stock price. No recent secondary market data is available.

How much is VisionHealth worth (valuation)?

Valuation information for VisionHealth is not publicly available.

Can I buy VisionHealth stock?

VisionHealth shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was VisionHealth's last funding round?

VisionHealth's most recent funding round was Seed on February 27, 2023.

Who are the main investors in VisionHealth?

Key investors in VisionHealth include Sanner Ventures, Vantage Value.

Will VisionHealth IPO soon?

No public IPO plans have been announced for VisionHealth.

How can I track VisionHealth secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VisionHealth's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMunich
Employee Range10
Year Founded2017
Last FundingFeb 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?